December 5, 2006
CONTACT: Karen Kreeger
Penn Researchers Discover Initial
Steps in the Development of Taste
(PHILADELPHIA) - Of the five senses, taste is one of the least understood, but now researchers at the University of Pennsylvania School of Medicine have come one step closer to understanding how the sense of taste develops. They have pinpointed a molecular pathway that regulates the development of taste buds. Using genetically engineered mice, they discovered that a signaling pathway activated by small proteins called Wnts is required for initiating taste-bud formation. They have also determined that Wnt proteins are required for hooking up the wiring of taste signals to the brain.
Senior author Sarah E. Millar, PhD, Associate Professor in the Departments of Dermatology and Cell and Developmental Biology, Penn postdoctoral fellow Fei Liu, PhD, and colleagues report their findings in the most recent online issue of Nature Genetics. “The developmental biology of taste is underexplored,” says Millar of her team’s impetus for the study.
The researchers demonstrated that blocking the action of Wnt proteins
in surface cells of the developing tongue prevents taste-bud formation,
while stimulating Wnt activity causes the formation of excessive numbers
of enlarged taste papillae that are able to attract taste-related nerve
fibers. This study represents the first genetic analysis of taste-organ
initiation in mammals. While these studies were performed in mice, the
researchers believe that their findings will also hold true for understanding
the basis of taste-bud development in humans.
The signaling pathway activated by Wnt proteins is critical to the development of many organ systems, and its inappropriate activation causes human diseases including colon cancer. In previous studies, Millar and colleagues have shown that this pathway is essential for initiating the formation of hair follicles and mammary glands in mice.
The sites of Wnt signaling are easily visualized in specially engineered transgenic mice, using an enzymatic assay. “We noticed in the tongue that there was this beautiful pattern of blue spots that correspond to the developing taste papillae,” says Millar. “This connected the Wnt pathway to their development.”
In the present study, the researchers found that in mice in which the actions of Wnt proteins were blocked, taste papilla buds completely failed to develop. Conversely, in mice in which Wnt signaling was over activated, their tongues were covered with many and large papillae and taste buds.
“Unlike most surface epithelial cells, taste buds have characteristics of neurons as well as skin. Like other types of epithelial cells they turn over and regenerate, but they also express chemoreceptors and make synapses with neurons,” explains Millar. The group studied how developing taste buds become wired into the nervous system. In early tongue development, neurons enter the tongue epithelium and make synapses with taste bud cells. This study confirmed that taste buds produce signals that attract nerve fibers to them. When taste-bud development was prevented by blocking Wnt signaling, the nerve fibers did not enter the tongue epithelium.
“They don’t know where to go on their own,” she says.
Millar also mentions that by now understanding the basis for the initiation of taste-papilla formation, the evolution and difference between species in the numbers and patterns of taste buds can be more fully explored. All animals that taste have taste buds, but there are differences, for example humans have more (around 200) taste papillae than mice, and they are arranged in a different pattern.
Future research directions will include determining whether Wnt signaling is also important for the periodic regeneration of taste buds from taste-bud stem cells that occurs throughout life in adult animals. Taste-bud regeneration can be affected by chemotherapy, so understanding this process will have important implications for patient care.
The research was supported by the National Institutes of Health. In addition to Millar and Liu, co-authors on the paper are: Natalie Gallant, Seshamma T. Reddy, and Thomas Andl, from Penn; Shoba Thirumangalathu and Linda Barlow from the University of Colorado Health Sciences Center; Steven Yang and Andrzej A. Dlugosz from the University of Michigan; Cristi L. Stoick-Cooper and Randall T. Moon from the Howard Hughes Medical Institute and University of Washington; and Makoto M. Taketo from Kyoto University.
PENN Medicine is a $2.9 billion enterprise dedicated to the related missions of medical education, biomedical research, and high-quality patient care. PENN Medicine consists of the University of Pennsylvania School of Medicine (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System.
Penn's School of Medicine is ranked #2 in the nation for receipt of NIH research funds; and ranked #3 in the nation in U.S. News & World Report's most recent ranking of top research-oriented medical schools. Supporting 1,400 fulltime faculty and 700 students, the School of Medicine is recognized worldwide for its superior education and training of the next generation of physician-scientists and leaders of academic medicine.The University of Pennsylvania Health System includes three hospitals, all of which have received numerous national patient-care honors [Hospital of the University of Pennsylvania; Pennsylvania Hospital, the nation's first hospital; and Penn Presbyterian Medical Center]; a faculty practice plan; a primary-care provider network; two multispecialty satellite facilities; and home care and hospice.